patient engagement

SECAUCUS, N.J., March 2, 2026 Quest Diagnostics (NYSE: DGX) has introduced Quest AI Companion, an AI-powered chat feature integrated...

SAN JOSE, Calif., January 20, 2026 — BrightInsight announced a $13 million strategic investment to accelerate development of its...

September 16, 2025 — San Diego, California Sanguine Biosciences has announced the expansion of its oncology biospecimen offerings through...